Er-Kang has a YoY expansion in sales of medicinal sucrose products

On 27 Aug., Hunan Er-Kang Pharmaceutical Co., Ltd. (Er-Kang) released the first-half performance report of 2019. During the reporting period, the Company achieved revenue of USD190.60 million (RMB1.35 billion), up by 37.07% YoY; and net profit attrib...

Sweeteners China News 1909

www.cnchemicals.com